Suppr超能文献

寻找“信号 2”:γδ T 细胞的共刺激要求。

Searching for "signal 2": costimulation requirements of γδ T cells.

机构信息

Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Avenida Professor Egas Moniz, 1649-028, Lisboa, Portugal.

出版信息

Cell Mol Life Sci. 2011 Jul;68(14):2345-55. doi: 10.1007/s00018-011-0698-2. Epub 2011 May 4.

Abstract

T cell activation requires the integration of signals that arise from various types of receptors. Although TCR triggering is a necessary condition, it is often not sufficient to induce full T-cell activation, as reflected in cell proliferation and cytokine secretion. This has been firmly demonstrated for conventional αβ T cells, for which a large panel of costimulatory receptors has been identified. By contrast, the area remains more obscure for unconventional, innate-like γδ T cells, as the literature has been scarce and at times contradictory. Here we review the current state of the art on the costimulatory requirements of γδ T cell activation. We highlight the roles of members of the immunoglobulin (like CD28 or JAML) or tumour necrosis factor receptor (like CD27) superfamilies of coreceptors, but also of more atypical costimulatory molecules, such as NKG2D or CD46. Finally, we identify various areas where our knowledge is still markedly insufficient, hoping to provoke future research on γδ T cell costimulation.

摘要

T 细胞的激活需要整合来自各种受体的信号。尽管 TCR 的触发是一个必要条件,但它通常不足以诱导完全的 T 细胞激活,这反映在细胞增殖和细胞因子分泌上。这在传统的 αβ T 细胞中得到了明确的证实,因为已经鉴定出了大量的共刺激受体。相比之下,对于非常规的、先天样的 γδ T 细胞,这一领域仍然更加模糊,因为文献很少,有时还相互矛盾。在这里,我们回顾了 γδ T 细胞激活的共刺激要求的最新进展。我们强调了免疫球蛋白(如 CD28 或 JAML)或肿瘤坏死因子受体(如 CD27)超家族的成员以及更非典型的共刺激分子(如 NKG2D 或 CD46)的作用。最后,我们确定了我们的知识仍然明显不足的各个领域,希望能激发未来关于 γδ T 细胞共刺激的研究。

相似文献

1
Searching for "signal 2": costimulation requirements of γδ T cells.寻找“信号 2”:γδ T 细胞的共刺激要求。
Cell Mol Life Sci. 2011 Jul;68(14):2345-55. doi: 10.1007/s00018-011-0698-2. Epub 2011 May 4.
9
Two pathways of costimulation through CD28.通过 CD28 的两条共刺激途径。
Immunol Res. 2009 Dec;45(2-3):159-72. doi: 10.1007/s12026-009-8097-6. Epub 2009 Feb 13.

引用本文的文献

3
Challenges and new technologies in adoptive cell therapy.过继细胞治疗中的挑战和新技术。
J Hematol Oncol. 2023 Aug 18;16(1):97. doi: 10.1186/s13045-023-01492-8.

本文引用的文献

5
A ligand for CD5 is CD5.CD5 的配体是 CD5。
J Immunol. 2010 Nov 15;185(10):6068-74. doi: 10.4049/jimmunol.0903823. Epub 2010 Oct 15.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验